037. Could somatostatin enhance the outcomes of chemotherapeutic treatment in small-cell carcinoma (SCLC)?

OBJECTIVE: Somatostatin is a peptide with a potent and broad antisecretory action, which makes it an invaluable drug target for the pharmacological management of pituitary adenomas and neuroendocrine tumors. Furthermore, somatostatin (SST) receptors (SSTR1, 2A and B, 3, 4 and 5) belong to the G prot...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Thorac Dis
Main Authors: Domvri, Kalliopi, Bougiouklis, Dimitrios, Zarogoulidis, Paul, Porpodis, Konstantinos, Xristoforidis, Manolis, Liaka, Alexandra, Eleutheriadou, Ellada, Organtzis, Ioannis, Kyriazis, George, Malecki, Bianka, Zarogoulidis, Konstantinos
Formato: Artigo
Idioma:Inglês
Publicado em: AME Publishing Company 2015
Assuntos:
The Pan Hellenic Congress Abstracts
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4332059/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2072-1439.2015.AB037
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados